Nevertheless, CML is a chronic hematopoietic disease derived from transformed long-term hematopoietic stem cells (LT-HSC) that can act as leukemic stem cells (LSC) and maintain the disease by signaling via STAT5 [34]. The gene discussed is STAT5A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.